From MSNBC
FDA Approves KAPIDEX^(TM) (Dexlansoprazole) Delayed Release Capsules for the Treatment of GERD
First Proton Pump Inhibitor (PPI) With a Dual Delayed Release^(TM) (DDR) Formulation

DEERFIELD, IL and OSAKA, JAPAN - Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA) approved KAPIDEX^(TM) (dexlansoprazole) delayed release capsules for the once-daily, oral treatment of heartburn associated with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE. KAPIDEX (30 mg and 60 mg) is the first proton pump inhibitor (PPI) with a Dual Delayed Release^(TM) (DDR) formulation designed to provide two separate releases of medication.

Read the full story: http://www.msnbc.msn.com/id/28940583/
Go to the Kapidex site (Takeda asks that we remind you that the site you are going to is owned by Takeda and is not related to the PAGER site.) https://www.kapidex.com/default.aspx